Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

休市中 05-03 16:00:00 EDT

2.52

-0.02

-0.79%

最高2.54	最低2.48	成交量5,230
今开2.54	昨收2.54	日振幅2.30%
总市值1,436万	流通市值1,188万	总股本570.00万
成交额1.31万	换手率0.11%	流通股本471.42万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":2.52,"timestamp":1714766400000,"preClose":2.54,"halted":0,"volume":5230,"delay":0,"floatShares":4714200,"shares":5699958,"eps":-0.464567,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"05-03 16:00:00 EDT","open":2.54,"high":2.54,"low":2.4815,"amount":13096.444569,"amplitude":0.023031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.464567,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":1,"adjPreClose":2.54,"adrRate":40,"volumeRatio":0.6440886643982505},"requestUrl":"/m/hq/s/IMRN/","defaultTab":"news","newsList":[{"id":"2432508953","title":"Immuron Limited盘中异动 大幅拉升7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432508953","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432508953?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:03","pubTimestamp":1714572197,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时03分，Immuron Limited股票出现波动，股价快速拉升7.68%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.19%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012203177a57dc61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012203177a57dc61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430201557","title":"Immuron Limited盘中异动 早盘快速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430201557","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430201557?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:08","pubTimestamp":1714144081,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日23时08分，Immuron Limited股票出现异动，股价大幅拉升6.08%。截至发稿，该股报2.58美元/股，成交量155股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.21%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262308018b57bd72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262308018b57bd72&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429146797","title":"Immuron Limited盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429146797","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429146797?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:24","pubTimestamp":1713896645,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时24分，Immuron Limited股票出现波动，股价快速下跌5.44%。截至发稿，该股报2.46美元/股，成交量1411股，换手率0.02%，振幅3.77%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.71%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240224067922b791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240224067922b791&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429922961","title":"Immuron Limited盘中异动 早盘快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429922961","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429922961?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:45","pubTimestamp":1713793511,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时45分，Immuron Limited股票出现异动，股价大幅上涨5.19%。截至发稿，该股报2.43美元/股，成交量7524股，换手率0.13%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.41%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422214512861e7d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422214512861e7d76&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428065400","title":"Immuron Limited盘中异动 早盘大幅下挫6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428065400","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428065400?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:42","pubTimestamp":1713534163,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时42分，Immuron Limited股票出现波动，股价急速下跌6.12%。截至发稿，该股报2.30美元/股，成交量1.35万股，换手率0.24%，振幅6.12%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.64%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192142447921e11a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192142447921e11a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427878874","title":"Immuron Limited盘中异动 大幅跳水5.41%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427878874","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427878874?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:30","pubTimestamp":1713274227,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时30分，Immuron Limited股票出现异动，股价大幅跳水5.41%。截至发稿，该股报2.45美元/股，成交量326股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.00%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621302787e80f64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621302787e80f64&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427757436","title":"Immuron Limited盘中异动 临近收盘股价大跌6.71%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427757436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427757436?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:51","pubTimestamp":1712951461,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时51分，Immuron Limited股票出现异动，股价快速跳水6.71%。截至发稿，该股报2.66美元/股，成交量6720股，换手率0.12%，振幅2.81%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.45%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413035102792040f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413035102792040f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424804311","title":"Immuron Limited盘中异动 股价大涨5.36%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424804311","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424804311?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:30","pubTimestamp":1712064625,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时30分，Immuron Limited股票出现异动，股价快速拉升5.36%。截至发稿，该股报2.75美元/股，成交量2376股，换手率0.04%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.17%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213025791e7c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213025791e7c8d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422194399","title":"Immuron Limited盘中异动 股价大跌6.12%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422194399","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422194399?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632966,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时36分，Immuron Limited股票出现波动，股价快速跳水6.12%。截至发稿，该股报2.61美元/股，成交量3967股，换手率0.07%，振幅1.62%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.03%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821360687e7cbf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821360687e7cbf5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422862609","title":"Immuron Limited盘中异动 急速上涨6.51%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422862609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422862609?lang=zh_cn&edition=full","pubTime":"2024-03-27 03:34","pubTimestamp":1711481646,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日03时34分，Immuron Limited股票出现波动，股价快速拉升6.51%。截至发稿，该股报2.78美元/股，成交量2.0118万股，换手率0.35%，振幅2.68%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.49%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032703340687e7bea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032703340687e7bea1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422543142","title":"Immuron Limited盘中异动 早盘快速拉升6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422543142","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422543142?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:01","pubTimestamp":1711375284,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时01分，Immuron Limited股票出现波动，股价急速上涨6.23%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.20%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325220124861e0e18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325220124861e0e18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421777338","title":"Immuron Limited盘中异动 大幅下挫5.26%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421777338","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421777338?lang=zh_cn&edition=full","pubTime":"2024-03-21 00:34","pubTimestamp":1710952494,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日00时34分，Immuron Limited股票出现异动，股价大幅跳水5.26%。截至发稿，该股报2.52美元/股，成交量3.0464万股，换手率0.53%，振幅6.82%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.06%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210034547a4dfdbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210034547a4dfdbc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420279108","title":"Immuron Limited盘中异动 早盘急速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420279108","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420279108?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:11","pubTimestamp":1710861105,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时11分，Immuron Limited股票出现异动，股价大幅下挫5.84%。截至发稿，该股报2.58美元/股，成交量2.1301万股，换手率0.37%，振幅4.36%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.05%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192311457a4db761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192311457a4db761&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472896","title":"Immuron Limited盘中异动 早盘急速下挫5.23%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472896","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472896?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:38","pubTimestamp":1710769122,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时38分，Immuron Limited股票出现异动，股价大幅下跌5.23%。截至发稿，该股报2.72美元/股，成交量8433股，换手率0.15%，振幅4.53%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.08%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821384287e79c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821384287e79c2b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419433188","title":"Immuron Limited盘中异动 快速上涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419433188","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419433188?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:28","pubTimestamp":1710523723,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时28分，Immuron Limited股票出现波动，股价急速拉升6.02%。截至发稿，该股报2.99美元/股，成交量4.7329万股，换手率0.83%，振幅10.28%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.32%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316012843861deba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316012843861deba2&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":-0.0455},{"period":"1month","weight":-0.0701},{"period":"3month","weight":0.4399},{"period":"6month","weight":0.509},{"period":"1year","weight":0.3125},{"period":"ytd","weight":0.344}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.236802},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.076928},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034557},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.002953},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.095664},{"month":6,"riseRate":0.4,"avgChangeRate":0.456496},{"month":7,"riseRate":0.5,"avgChangeRate":0.025453},{"month":8,"riseRate":0.5,"avgChangeRate":-0.026357},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.083718},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.067505},{"month":11,"riseRate":0.571429,"avgChangeRate":0.04362},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.090493}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}